ATE326985T1 - Lyophilisierte pharmazeutische zusammensetzung von propofol - Google Patents
Lyophilisierte pharmazeutische zusammensetzung von propofolInfo
- Publication number
- ATE326985T1 ATE326985T1 AT03702813T AT03702813T ATE326985T1 AT E326985 T1 ATE326985 T1 AT E326985T1 AT 03702813 T AT03702813 T AT 03702813T AT 03702813 T AT03702813 T AT 03702813T AT E326985 T1 ATE326985 T1 AT E326985T1
- Authority
- AT
- Austria
- Prior art keywords
- propofol
- pharmaceutical composition
- lyophilized pharmaceutical
- relates
- composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004134 propofol Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200200929 | 2002-02-01 | ||
| US40163302P | 2002-08-06 | 2002-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE326985T1 true ATE326985T1 (de) | 2006-06-15 |
Family
ID=27669352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03702813T ATE326985T1 (de) | 2002-02-01 | 2003-01-29 | Lyophilisierte pharmazeutische zusammensetzung von propofol |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20050239746A1 (de) |
| EP (1) | EP1469886B8 (de) |
| JP (1) | JP2005522422A (de) |
| CN (1) | CN1625414A (de) |
| AT (1) | ATE326985T1 (de) |
| AU (1) | AU2003205930B2 (de) |
| BR (1) | BR0307518A (de) |
| CA (1) | CA2474710A1 (de) |
| DE (1) | DE60305438T2 (de) |
| MX (1) | MXPA04007328A (de) |
| NZ (1) | NZ534598A (de) |
| WO (1) | WO2003063824A2 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070028331A (ko) * | 2004-03-10 | 2007-03-12 | 쉬모다 바이오테크(피티와이) 리미티드 | 안정된 주사용 디클로페낙 조성물 |
| US20060198891A1 (en) | 2004-11-29 | 2006-09-07 | Francois Ravenelle | Solid formulations of liquid biologically active agents |
| US20090069445A1 (en) | 2005-04-13 | 2009-03-12 | Otsuka Pharmaceutical Factory, Inc | Propofol-containing fat emulsions |
| MX2008001981A (es) * | 2005-08-12 | 2008-03-25 | Bharat Serums & Vaccines Ltd | Composiciones anestesicas acuosas que comprenden propofol. |
| CA2647348A1 (en) | 2006-03-28 | 2007-10-04 | Javelin Pharmaceuticals, Inc. | Formulations of low dose diclofenac and beta-cyclodextrin |
| EP2106786A1 (de) * | 2008-04-04 | 2009-10-07 | Roewer, Norbert, Univ.-Prof. Dr. med. | Pharmazeutische Zubereitung mit permethyliertem Cyclodextrin |
| EP2484350B1 (de) * | 2011-02-04 | 2016-04-20 | Roewer, Norbert, Univ.-Prof. Dr. med. | Pharmazeutische Zubereitung, enthaltend einen Komplex eines Propofolsalzes mit einem Cyclodextrin |
| US9492552B2 (en) | 2011-11-29 | 2016-11-15 | Jurox Pty Ltd | Injectable aqueous pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent, and a preservative |
| CN103172658B (zh) * | 2011-12-26 | 2016-01-20 | 宜昌人福药业有限责任公司 | 一种适合药用的前体药物晶型、制备方法及药用组合物 |
| US9925274B2 (en) | 2012-11-15 | 2018-03-27 | Sapiotec Gmbh | Delphinidin complex as an antiphlogistic or immunosuppressive active ingredient |
| HK1215392A1 (zh) | 2012-12-11 | 2016-08-26 | 赛博尔泰克股份公司 | 用於对抗黑色素瘤细胞的飞燕草素 |
| EP2913050A1 (de) * | 2014-02-28 | 2015-09-02 | SapioTec GmbH | Verfahren zur Herstellung eines Flurankomplexes |
| CN104523591B (zh) * | 2014-12-19 | 2019-01-18 | 西安力邦肇新生物科技有限公司 | 无致敏性、无痛丙泊酚脂肪微乳冻干制剂配方和制备方法 |
| CN111529695A (zh) * | 2020-04-30 | 2020-08-14 | 首都医科大学附属北京康复医院（北京工人疗养院） | 一种环糊精可溶性ace2及其制备方法和应用 |
| KR20220057901A (ko) * | 2020-10-30 | 2022-05-09 | 현대자동차주식회사 | 차아염소산수를 이용한 차량용 살균장치 및 그 제어방법 |
| FR3117337B1 (fr) | 2020-12-10 | 2023-04-28 | Centre Hospitalier Univ De Lille | Composition pharmaceutique contenant du propofol, une cyclodextrine ou un dérivé de cyclodextrine et un sel pharmaceuticalement acceptable |
| IL315046A (en) * | 2022-02-18 | 2024-10-01 | Beren Therapeutics P B C | Treatment of hypertriglyceridemia with 2-hydroxypropyl-beta-cyclodextrin |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA828580B (en) * | 1981-12-23 | 1983-10-26 | Schering Corp | Interferon formulations |
| ZA962214B (en) * | 1995-04-10 | 1996-10-07 | Farmarc Nederland Bv | Pharmaceutical composition |
| WO1996041646A2 (en) * | 1995-06-13 | 1996-12-27 | Dyer, Alison, Margaret | Pharmaceutical compositions containing lornoxicam and cyclodextrin |
| DE69721235T2 (de) * | 1996-02-19 | 2004-02-05 | Amersham Health As | Verbesserungen an (oder im bezug auf) kontrastmittel |
| US6407278B2 (en) * | 1998-11-16 | 2002-06-18 | Medimmune Oncology, Inc. | Stable amorphous amifostine compositions and methods for the preparation and use of the same |
| US6440414B1 (en) * | 1999-10-01 | 2002-08-27 | Amgen Inc. | Pharmaceutical compositions of fibrinolytic agent |
| AU770165B2 (en) * | 1999-10-29 | 2004-02-12 | Merck Sharp & Dohme Corp. | Process for formulation of carbapenem antibiotic compositions |
| IN187686B (de) * | 2000-06-21 | 2002-06-08 | Bharat Serums & Vaccines Ltd | |
| US20030055023A1 (en) * | 2001-03-20 | 2003-03-20 | Rajewski Roger A. | Formulations containing etomidate and a sulfoalkyl ether cyclodextrin |
-
2003
- 2003-01-29 CN CNA038031442A patent/CN1625414A/zh active Pending
- 2003-01-29 CA CA002474710A patent/CA2474710A1/en not_active Abandoned
- 2003-01-29 DE DE60305438T patent/DE60305438T2/de not_active Expired - Lifetime
- 2003-01-29 US US10/503,067 patent/US20050239746A1/en not_active Abandoned
- 2003-01-29 WO PCT/IB2003/000266 patent/WO2003063824A2/en not_active Ceased
- 2003-01-29 NZ NZ534598A patent/NZ534598A/en not_active IP Right Cessation
- 2003-01-29 JP JP2003563518A patent/JP2005522422A/ja active Pending
- 2003-01-29 EP EP03702813A patent/EP1469886B8/de not_active Expired - Lifetime
- 2003-01-29 AT AT03702813T patent/ATE326985T1/de not_active IP Right Cessation
- 2003-01-29 AU AU2003205930A patent/AU2003205930B2/en not_active Ceased
- 2003-01-29 BR BR0307518-4A patent/BR0307518A/pt not_active IP Right Cessation
- 2003-01-29 MX MXPA04007328A patent/MXPA04007328A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003205930B2 (en) | 2007-08-16 |
| JP2005522422A (ja) | 2005-07-28 |
| DE60305438T2 (de) | 2006-12-21 |
| WO2003063824A3 (en) | 2004-06-17 |
| EP1469886A2 (de) | 2004-10-27 |
| EP1469886B1 (de) | 2006-05-24 |
| WO2003063824A2 (en) | 2003-08-07 |
| CN1625414A (zh) | 2005-06-08 |
| NZ534598A (en) | 2004-11-26 |
| BR0307518A (pt) | 2004-12-28 |
| US20050239746A1 (en) | 2005-10-27 |
| EP1469886B8 (de) | 2008-01-09 |
| DE60305438D1 (de) | 2006-06-29 |
| CA2474710A1 (en) | 2003-08-07 |
| MXPA04007328A (es) | 2005-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60305438D1 (de) | Lyophilisierte pharmazeutische zusammensetzung von propofol | |
| IL154888A0 (en) | Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid | |
| DK1187928T3 (da) | Viruslignende partikler, fremstilling og anvendelse ved screening samt ved funktionel genomics | |
| BR0113663A (pt) | Composições de pelìcula de pectina | |
| FR2841900B1 (fr) | Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations | |
| ATE250431T1 (de) | Verbesserte zusammensetzungen mit unkomplexiertem cyclodextrin zur geruchskontrolle | |
| SG170087A1 (en) | Pharmaceutical compositions | |
| NO20072733L (no) | Doseformer | |
| ATE350377T1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
| CY1118180T1 (el) | Μεθοδος για παρασκευη στερεας φαρμακευτικης συνθεσης | |
| EP1505990A4 (de) | Verfahren zur behandlung von hepatitis | |
| BRPI0508700A (pt) | uso de sns-595, composição farmacêutica, e, pó liofilizado | |
| TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
| BR0308486A (pt) | Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga | |
| DE60113445D1 (de) | Substanzen mit verzweigten linkermolekülen | |
| DE60143363D1 (de) | Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern | |
| WO2005034861A3 (en) | A dried biotherapeutic composition, uses, and device and methods for administration thereof | |
| DE602004017326D1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
| DE69924304D1 (de) | N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin | |
| EA200200313A1 (ru) | Применение доцетаксела для лечения печеночно-клеточного рака | |
| EA200601288A1 (ru) | Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение | |
| EA200501301A1 (ru) | Ментоловые растворы лекарственных препаратов | |
| HRP20080597T3 (en) | Cancer combination therapy comprising azd2171 and zd1839 | |
| GB0216940D0 (en) | Improvements in or relating to organic compounds | |
| AR048672A1 (es) | Tabletas de desintegracion que comprenden licarbazepina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |